Candriam Luxembourg S.C.A. »

Disc Medicine shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 80k 57.76

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Perceptive Advisors
Frazier Life Sciences Management
Vanguard Group
T. Rowe Price Associates
Deerfield Management Company
Henderson Group
Alliancebernstein
Caption Management
5AM Venture Management
Franklin Resources
Citadel Advisors
Ikarian Capital

View all funds holding Disc Medicine